Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure

Background: As of 8 April 2021, a total of 2.9 million people have died with or from the coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021, the European Medicines Agency (EMA) approved a COVID-19 vaccine developed by Oxford University and AstraZeneca (AZD1222, Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Marc E., Luz, Beate, Niehaus, Ludwig, Bhogal, Pervinder, Bäzner, Hansjörg, Henkes, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069989/
https://www.ncbi.nlm.nih.gov/pubmed/33918932
http://dx.doi.org/10.3390/jcm10081599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069989/
https://www.ncbi.nlm.nih.gov/pubmed/33918932
http://dx.doi.org/10.3390/jcm10081599

Ejemplares similares